Maternal Obesity and Developmental Health Outcomes

Maternal obesity has emerged as a global public-health challenge with profound implications for both mother and child. Excess adiposity before and during pregnancy disrupts maternal metabolism, fosters a pro-inflammatory intrauterine environment and alters placental function, collectively influencing foetal growth trajectories and long-term offspring health. Children born to mothers with obesity face elevated risks of gestational diabetes, large-for-gestational-age birth, cardiovascular dysfunction, neurodevelopmental disorders and metabolic disease later in life. Underlying mechanisms span dysregulated nutrient transport, epigenetic reprogramming, alterations in hypothalamic circuitry and compromised pancreatic β-cell capacity. These insights highlight the need for preconception weight optimisation, tailored nutritional support during gestation and early life interventions to mitigate the intergenerational cycle of obesity and its associated morbidities.

Research from Nature Portfolio

Recent studies have applied high-resolution molecular profiling to decipher how maternal diet programmes offspring neural development. One investigation used single-nucleus transcriptomic analysis of the mouse hypothalamus at peak lactation to reveal that maternal high-fat feeding expands specific neuronal subtypes—histaminergic, arginine vasopressin/retinoic acid receptor-related orphan receptor β and agouti-related peptide/neuropeptide Y cells—predominantly in male offspring. Concomitant increases in astrocyte–neuron interactions were observed, indicating that maternal dietary fat reshapes the cellular architecture of hypothalamic circuits governing energy balance. This cellular atlas offers a blueprint for understanding sex-specific vulnerability to metabolic disease and underscores the critical window of lactation in developmental programming.

Maternal Obesity and Developmental Health Outcomes publication trend

The graph below shows the total number of articles in maternal obesity and developmental health outcomes across all publications each year (not limited to Nature Index journals).

Technical terms

Body Mass Index (BMI): A measure of body fat based on weight and height, used to classify underweight, normal weight, overweight and obesity.

Gestational Diabetes Mellitus (GDM): New-onset glucose intolerance first identified during pregnancy.

Single-Nucleus Transcriptomics: An approach to profile gene expression in individual cell nuclei, enabling the resolution of diverse cell types within complex tissues.

Large-for-Gestational Age (LGA): A term for infants whose birthweight exceeds the 90th percentile for their gestational age.

Hypothalamic Neuronal Subpopulations: Distinct groups of nerve cells in the hypothalamus that regulate energy homeostasis, appetite and neuroendocrine functions.

References

1. Maternal dietary fat during lactation shapes single nucleus transcriptomic profile of postnatal offspring hypothalamus in a sexually dimorphic manner in mice. Nature Communications (2024).
2. Adverse pregnancy outcomes attributable to overweight and obesity across maternal birth regions: a Swedish population-based cohort study. The Lancet Public Health (2024).
3. Multiparity increases the risk of diabetes by impairing the proliferative capacity of pancreatic β cells. Experimental & Molecular Medicine (2023).